Trials / Conditions / Active Systemic Lupus Erythematosus
Active Systemic Lupus Erythematosus
6 registered clinical trials studyying Active Systemic Lupus Erythematosus — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE) NCT07311200 | InventisBio Co., Ltd | Phase 2 |
| Completed | Anifrolumab Asian PhIII Efficacy Study for Systemic Lupus Erythematosus (SLE) NCT04931563 | AstraZeneca | Phase 3 |
| Terminated | Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus NCT04680637 | Amgen | Phase 2 |
| Completed | Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus NCT02794285 | AstraZeneca | Phase 3 |
| Completed | Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythemato NCT02446899 | AstraZeneca | Phase 3 |
| Completed | Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lup NCT02446912 | AstraZeneca | Phase 3 |